Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
Mitral Valve Prolapse | 1 | 2019 | 24 | 0.79 | Why? |
Gap Junctions | 1 | 2017 | 18 | 0.72 | Why? |
Mechanotransduction, Cellular | 1 | 2017 | 28 | 0.72 | Why? |
Pulmonary Gas Exchange | 2 | 2020 | 414 | 0.71 | Why? |
Cell Membrane Permeability | 1 | 2017 | 84 | 0.69 | Why? |
Cell Adhesion | 1 | 2017 | 230 | 0.66 | Why? |
Models, Cardiovascular | 1 | 2017 | 153 | 0.64 | Why? |
Respiratory Mechanics | 1 | 2020 | 585 | 0.60 | Why? |
Mitral Valve | 1 | 2019 | 342 | 0.59 | Why? |
Ventilator-Induced Lung Injury | 1 | 2018 | 260 | 0.58 | Why? |
Extracorporeal Membrane Oxygenation | 3 | 2020 | 5002 | 0.44 | Why? |
Respiratory Insufficiency | 3 | 2020 | 7301 | 0.42 | Why? |
Heart | 1 | 2019 | 1791 | 0.39 | Why? |
Respiration, Artificial | 4 | 2021 | 22116 | 0.33 | Why? |
Endothelial Cells | 1 | 2017 | 2048 | 0.33 | Why? |
Critical Illness | 4 | 2021 | 17281 | 0.25 | Why? |
Myocardial Infarction | 1 | 2019 | 3361 | 0.25 | Why? |
Neoplasms, Hormone-Dependent | 1 | 2021 | 25 | 0.23 | Why? |
Micropore Filters | 1 | 2020 | 51 | 0.21 | Why? |
Tachycardia, Sinus | 1 | 2019 | 43 | 0.20 | Why? |
Biomarkers, Pharmacological | 1 | 2020 | 150 | 0.20 | Why? |
Influenza, Human | 2 | 2021 | 10779 | 0.19 | Why? |
Blood Vessels | 1 | 2021 | 228 | 0.19 | Why? |
Shear Strength | 1 | 2017 | 17 | 0.18 | Why? |
Thrombosis | 1 | 2020 | 7504 | 0.17 | Why? |
Stress, Mechanical | 1 | 2017 | 143 | 0.17 | Why? |
Pneumonia, Viral | 6 | 2020 | 243684 | 0.17 | Why? |
Coronavirus Infections | 6 | 2020 | 253789 | 0.17 | Why? |
Neovascularization, Pathologic | 1 | 2021 | 305 | 0.17 | Why? |
Vasodilator Agents | 1 | 2020 | 344 | 0.16 | Why? |
Androgen Antagonists | 1 | 2021 | 404 | 0.16 | Why? |
Pandemics | 8 | 2021 | 389249 | 0.16 | Why? |
Critical Care | 1 | 2020 | 14081 | 0.16 | Why? |
Lung | 3 | 2020 | 31049 | 0.16 | Why? |
Reference Standards | 1 | 2020 | 1163 | 0.15 | Why? |
Vasoconstrictor Agents | 1 | 2020 | 714 | 0.15 | Why? |
Lung Diseases | 2 | 2020 | 2361 | 0.15 | Why? |
Fluid Therapy | 1 | 2020 | 628 | 0.15 | Why? |
Mitral Valve Insufficiency | 1 | 2019 | 302 | 0.14 | Why? |
Evidence-Based Practice | 1 | 2020 | 693 | 0.14 | Why? |
Wound Healing | 1 | 2018 | 424 | 0.14 | Why? |
Exercise Test | 1 | 2020 | 911 | 0.13 | Why? |
Administration, Inhalation | 1 | 2020 | 1647 | 0.13 | Why? |
Cell Membrane | 1 | 2018 | 743 | 0.13 | Why? |
Respiration | 1 | 2018 | 729 | 0.13 | Why? |
Renal Insufficiency | 1 | 2020 | 810 | 0.12 | Why? |
Phenotype | 2 | 2021 | 4037 | 0.12 | Why? |
Drug Monitoring | 1 | 2020 | 1408 | 0.12 | Why? |
Positive-Pressure Respiration | 1 | 2020 | 1160 | 0.11 | Why? |
Betacoronavirus | 6 | 2020 | 204454 | 0.11 | Why? |
Renal Replacement Therapy | 1 | 2020 | 1530 | 0.11 | Why? |
Humans | 19 | 2021 | 930598 | 0.10 | Why? |
Patient Positioning | 1 | 2020 | 1505 | 0.10 | Why? |
Respiratory Protective Devices | 1 | 2020 | 1637 | 0.09 | Why? |
Prone Position | 1 | 2020 | 1861 | 0.09 | Why? |
Prostatic Neoplasms | 1 | 2021 | 1637 | 0.09 | Why? |
Body Mass Index | 1 | 2021 | 4306 | 0.09 | Why? |
Heparin | 1 | 2020 | 2600 | 0.08 | Why? |
Smoking | 1 | 2020 | 3358 | 0.08 | Why? |
Computer Simulation | 2 | 2021 | 4982 | 0.08 | Why? |
Cells, Cultured | 1 | 2017 | 5835 | 0.08 | Why? |
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 2984 | 0.08 | Why? |
Cough | 1 | 2019 | 4891 | 0.07 | Why? |
Echocardiography | 1 | 2019 | 3661 | 0.07 | Why? |
Electrocardiography | 1 | 2019 | 3957 | 0.07 | Why? |
Intubation, Intratracheal | 1 | 2020 | 3962 | 0.07 | Why? |
Diagnosis, Differential | 1 | 2019 | 7220 | 0.07 | Why? |
Hypoxia | 1 | 2019 | 3626 | 0.07 | Why? |
Radiography, Thoracic | 1 | 2019 | 5486 | 0.06 | Why? |
Fever | 1 | 2019 | 7795 | 0.06 | Why? |
Equipment Failure Analysis | 1 | 2020 | 94 | 0.05 | Why? |
Factor Xa | 1 | 2020 | 113 | 0.05 | Why? |
Obesity | 1 | 2021 | 7388 | 0.05 | Why? |
Heart Failure | 1 | 2020 | 6638 | 0.05 | Why? |
Hypertension | 1 | 2020 | 8895 | 0.05 | Why? |
Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
Cohort Studies | 1 | 2020 | 36005 | 0.04 | Why? |
Massachusetts | 1 | 2021 | 1279 | 0.04 | Why? |
Oxygen Consumption | 1 | 2020 | 711 | 0.04 | Why? |
Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
Male | 6 | 2021 | 367725 | 0.04 | Why? |
Middle Aged | 4 | 2021 | 270681 | 0.03 | Why? |
Adult | 2 | 2020 | 244371 | 0.03 | Why? |
Disease Progression | 2 | 2021 | 13580 | 0.03 | Why? |
Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.03 | Why? |
Feasibility Studies | 1 | 2020 | 3467 | 0.03 | Why? |
Retrospective Studies | 2 | 2021 | 105322 | 0.03 | Why? |
Aged, 80 and over | 1 | 2020 | 88759 | 0.02 | Why? |
Clinical Protocols | 1 | 2020 | 2734 | 0.02 | Why? |
Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
Blood Coagulation | 1 | 2020 | 2768 | 0.02 | Why? |
Aged | 2 | 2021 | 215776 | 0.02 | Why? |
Female | 3 | 2021 | 380317 | 0.02 | Why? |
Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
Immunity, Innate | 1 | 2021 | 6570 | 0.01 | Why? |
Models, Theoretical | 1 | 2021 | 6659 | 0.01 | Why? |
Risk Factors | 2 | 2021 | 71621 | 0.01 | Why? |
Clinical Trials as Topic | 1 | 2021 | 7330 | 0.01 | Why? |
Anticoagulants | 1 | 2020 | 9563 | 0.01 | Why? |
Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
Hardin's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(102)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(82)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_